Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$0.82 - $1.33 $24,022 - $38,963
29,296 New
29,296 $24,000
Q1 2021

Jul 21, 2021

SELL
$1.66 - $15.81 $272,907 - $2.6 Million
-164,402 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$0.28 - $2.6 $58,151 - $539,981
-207,685 Reduced 55.82%
164,402 $301,000
Q3 2020

Oct 30, 2020

BUY
$0.2 - $0.72 $37,896 - $136,425
189,480 Added 103.76%
372,087 $115,000
Q2 2020

Aug 05, 2020

BUY
$0.22 - $0.46 $40,173 - $83,999
182,607 New
182,607 $40,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $195M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.